Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02947971 · ClinicalTrials.gov registry record · NA
Pilot Study for TCE Imaging of the Esophagus Using an OFDI Capsule With a Compact Imaging System
A NA study of Barrett's Esophagus, sponsored by Massachusetts General Hospital.
- Recruiting
- Registry status
- NA
- Development phase
- 120
- Enrollment target
- 1
- Study location
NCT02947971: Recruiting NA study of Barrett's Esophagus, sponsored by Massachusetts General Hospital.
NCT02947971 is a NA study of Barrett's Esophagus that is actively recruiting participants, run by Massachusetts General Hospital. The registered enrollment target is 120 participants, below the 519-participant average among 22 other Barrett's Esophagus trials with a reported enrollment target (77% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02947971, a NA study of Barrett's Esophagus, is actively recruiting participants, sponsored by Massachusetts General Hospital.
- RECRUITING
- Registry status
- NA
- Development phase
- 120 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of this research is to test a distal scanning capsule and a compact redesigned version of the OFDI imaging system in healthy and BE participants to assess ease of use, safety and feasibility in preparation for its use in a multicenter clinical trial.
Primary Outcome
Images obtained from the CIS will be assessed for quality and compared to images acquired from the previous imaging system
Conditions Studied
Interventions
- DEVICE Experimental OFDI Imaging
Study Locations (1)
Massachusetts
- Massachusetts General hospital - Boston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 120 participants |
| Start Date | 2016-04-15 |
| Est. Completion | 2028-12 |
| Phase | NA |
What NCT02947971 shows while recruiting
NCT02947971 is an interventional study that assigns participants to a tested intervention. The registered 120 participants enrollment target is mid-sized for trials with a published cap, below the 519-participant average among 22 other Barrett's Esophagus trials with a reported enrollment target (77% lower).
The record links to 1 condition, with Barrett's Esophagus appearing as the primary indexed condition, and to 1 intervention - of which Experimental OFDI Imaging is the first listed.
NCT02947971 reports a single indexed study location in Massachusetts.
Frequently Asked Questions
What is clinical trial NCT02947971 about?
NCT02947971 is a clinical study titled "Pilot Study for TCE Imaging of the Esophagus Using an OFDI Capsule With a Compact Imaging System". The goal of this research is to test a distal scanning capsule and a compact redesigned version of the OFDI imaging system in healthy and BE participants to assess ease of use, safety and feasibility in preparation for its use in a multicenter clinical trial.
What is the current status of trial NCT02947971?
This trial is currently recruiting. It is a NA study. The enrollment target is 120 participants. The study started on 2016-04-15. Estimated completion is 2028-12.
What conditions does trial NCT02947971 study?
This clinical trial studies the following conditions: Barrett's Esophagus.
What interventions are being tested in trial NCT02947971?
The interventions under investigation include: Experimental OFDI Imaging (DEVICE).
Who is sponsoring clinical trial NCT02947971?
This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02947971 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Barrett's Esophagus
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT02947971's enrollment target sits among peer trials
120 7th of 22 higher than 16 of 22 other Barrett's Esophagus trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Barrett's Esophagus trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Navicam for Detection of Barrett's Esophagus
RECRUITING · NA
-
Surveillance and Image-Guided Biopsy of the Esophagus Using an OFDI Capsule
ACTIVE NOT RECRUITING · NA
-
Optical Coherence Tomography (OCT) Based Screening of Esophagus and Gastroesophageal Junction
COMPLETED · NA
-
Trial to Assess the Effects of an Antimicrobial Mouthwash on the Esophageal Microbiome
COMPLETED · NA
-
Comparison of Treatments for Barrett's Esophagus With High-Grade Dysplasia/Early Adenocarcinoma
COMPLETED · NA
-
Progression of Gastroesophageal Reflux Disease and Barrett's Esophagus and the Creation of a Barrett's Registry
RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01174108 · 120 participants · Phase 2
Allogeneic Hematopoietic Stem Cell Transplantation for Severe Aplastic Anemia and Other Bone Marrow Failure Syndromes Using G-CSF Mobilized CD34+ Selected Hematopoietic Precursor Cells Co-Infused With a Reduced Dose of Non-Mobilized Donor T-cells
- NCT01627301 · 120 participants · NA
Sympathetic Overactivity in Post-traumatic Stress Disorder
- NCT02025023 · 120 participants · Phase 3
Local 5-Fluorouracil Injection for the Treatment of Chalazia: A Prospective, Comparative Study
- NCT02128906 · 120 participants · Phase 2
Radiotherapy With Cisplatin vs. Docetaxel-cetuximab in HNSCC: ERCC1 Biomarker Enrichment and Interaction Design
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI